Ralph Naumann

5.7k total citations · 1 hit paper
52 papers, 2.9k citations indexed

About

Ralph Naumann is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Ralph Naumann has authored 52 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 16 papers in Hematology. Recurrent topics in Ralph Naumann's work include Lymphoma Diagnosis and Treatment (20 papers), Multiple Myeloma Research and Treatments (9 papers) and Cancer Treatment and Pharmacology (8 papers). Ralph Naumann is often cited by papers focused on Lymphoma Diagnosis and Treatment (20 papers), Multiple Myeloma Research and Treatments (9 papers) and Cancer Treatment and Pharmacology (8 papers). Ralph Naumann collaborates with scholars based in Germany, France and Austria. Ralph Naumann's co-authors include Gerhard Ehninger, Andreas K. Buck, Rodney J. Hicks, Klemens Scheidhauer, Felix M. Mottaghy, Josée M. Zijlstra, Barry A. Siegel, Wolfgang Weber, Otto S. Hoekstra and Bruce D. Cheson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ralph Naumann

49 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

2007 967 citations Malik E. Juweid, Sigrid Stroobants et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Ralph Naumann

Since Specialization

Citations

This map shows the geographic impact of Ralph Naumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Naumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Naumann more than expected).

Fields of papers citing papers by Ralph Naumann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Naumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Naumann. The network helps show where Ralph Naumann may publish in the future.

Co-authorship network of co-authors of Ralph Naumann

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Naumann. A scholar is included among the top collaborators of Ralph Naumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Naumann. Ralph Naumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany 2024 ·SHILAP Revista de lepidopterología ·(unknown), Cyrus Khandanpour, Knut Wendelin, Fuat Oduncu, Christoph Kimmich, Ralph Naumann, Miriam Kull, Hartmut Goldschmidt, (unknown), Claudia Kiewitz, Hans Salwender	0
2	Beantragung der Bewilligung von akademischen Multicenterstudien bei deutschen Ethikkommissionen 2013 ·Oncology Research and Treatment ·Nicola Gökbuget, Ralph Naumann, (unknown)	4
3	Akademische multizentrische Studien im Fokus: Auswirkungen der Arzneimittelgesetzgebung auf Therapieoptimierungsstudien in der Hämatologie/Onkologie 2013 ·Oncology Research and Treatment ·(unknown), (unknown), Michael Fuchs, Michael Hallek, Norbert Marschner, Ralph Naumann, Christoph Röllig, Susanne Saußele, Hans Tesch, Nicola Gökbuget	2
4	A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma 2008 ·European Journal Of Haematology ·M von Lilienfeld-Toal, Corinna Hahn‐Ast, (unknown), Florian Hoffmann, Ralph Naumann, Ralf C. Bargou, Gordon Cook, Axel Glasmacher	56
5	Rituximab Added to First-Line Mitoxantrone, Chlorambucil, and Prednisolone Chemotherapy Followed by Interferon Maintenance Prolongs Survival in Patients With Advanced Follicular Lymphoma: An East German Study Group Hematology and Oncology Study 2007 ·Journal of Clinical Oncology ·Michael Herold, Antje Haas, Stefanie Srock, Sabine Neser, Haifa Kathrin Al‐Ali, Andreas Neubauer, Gottfried Dölken, Ralph Naumann, Wolfgang Knauf, Mathias Freund, Robert Rohrberg, K. Höffken, Astrid Franke, T. H. Ittel, E. Kettner, Ursula Haak, Ulrich Mey, C. Klinkenstein, (unknown), (unknown)	371
6	Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma breakdown → 2007 ·Journal of Clinical Oncology ·Malik E. Juweid, Sigrid Stroobants, Otto S. Hoekstra, Felix M. Mottaghy, Markus Dietlein, Ali Guermazi, Gregory A. Wiseman, Lale Kostakoğlu, Klemens Scheidhauer, Andreas K. Buck, Ralph Naumann, Karoline Spaepen, Rodney J. Hicks, Wolfgang Weber, Sven N. Reske, Markus Schwaiger, Lawrence H. Schwartz, Josée M. Zijlstra, Barry A. Siegel, Bruce D. Cheson	967
7	A systematic review of phase‐II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma 2006 ·British Journal of Haematology ·Axel Glasmacher, Corinna Hahn, Florian Hoffmann, Ralph Naumann, Hartmut Goldschmidt, Marie von Lilienfeld‐Toal, Katjana Orlopp, Ingo Schmidt‐Wolf, Marcus Gorschlüter	176
8	Diagnostik des Hodgkin-Lymphoms — state of the art 2005 ·Der Onkologe ·A Goßmann, Markus Dietlein, Carsten Kobe, Ralph Naumann	0
9	Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma 2004 ·British Journal of Cancer ·Ralph Naumann, Bettina Beuthien‐Baumann, (unknown), Jan Schulze, Annette Hänel, Jan Bredow, G Kühnel, J. Kropp, Mathias Hänel, Michael Laniado, J. Kotzerke, Gerhard Ehninger	106
10	A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly) 2004 ·Annals of Oncology ·Veronika Ballová, Jens Ulrich Rüffer, Heinz Haverkamp, Beate Pfistner, H. K. Müller-Hermelink, E. Dühmke, P. Worst, (unknown), Ralph Naumann, Marcus Hentrich, Hans‐Theodor Eich, Andreas Josting, Markus Löffler, Volker Diehl, Andreas Engert	109
11	Simultaneous Occurrence of Hodgkin's Lymphoma and Eosinophilic Granuloma: A Potential Pitfall in Positron Emission Tomography Imaging 2002 ·Clinical Lymphoma ·Ralph Naumann, Bettina Beuthien‐Baumann, Rainer Fischer, Thomas Kittner, Jan Bredow, J. Kropp, D. Ockert, Gerhard Ehninger	20
12	Prognostic value of positron emission tomography in the evaluation of post‐treatment residual mass in patients with Hodgkin's disease and non‐Hodgkin's lymphoma 2001 ·British Journal of Haematology ·Ralph Naumann, (unknown), Bettina Beuthien‐Baumann, Jan Bredow, J. Kropp, Thomas Kittner, (unknown), Gerhard Ehninger	154
13	Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation 2001 ·British Journal of Haematology ·Ulrich S. Schuler, Ulf Renner, Frank Kroschinsky, (unknown), Andreas Jenke, Ralph Naumann, Martin Bornhäuser, H. Joachim Deeg, Gerhard Ehninger	34
14	Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life‐threatening vincristine neurotoxicity 2001 ·British Journal of Haematology ·Ralph Naumann, (unknown), Ulrike Reuner, Frank Kroschinsky, Bernd Rautenstrauß, Gerhard Ehninger	35
15	Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation 2001 ·Bone Marrow Transplantation ·(unknown), Ralph Naumann, Torsten Zuberbier, Rainer Ordemann, H. Baurmann, J. Beyer, W. Siegert, Martin Bornhäuser, Gerhard Ehninger	10
16	Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma 2001 ·Journal of Cancer Research and Clinical Oncology ·Mathias Hänel, Nicolaus Kröger, Frank Kroschinsky, Josef Birkmann, Annette Hänel, Regina Herbst, Ralph Naumann, (unknown), Gerhard Ehninger, A Zander, F. Fiedler	4
17	A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes 2001 ·Clinical & Laboratory Haematology ·Uta Oelschlaegel, (unknown), Christine Arnoulet, D Sainty, (unknown), Ralph Naumann, (unknown), Gerhard Ehninger	29
18	Foscarnet - an alternative for cytomegalovirus prophylaxis after allogeneic stem cell transplantation? 2000 ·Annals of Hematology ·Rainer Ordemann, Ralph Naumann, G Geissler, Frank Kroschinsky, Martin Bornhäuser, Rainer Schwerdtfeger, Gerhard Ehninger	7
19	Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin 2000 ·Bone Marrow Transplantation ·Martin Bornhäuser, Christian Thiede, Ulrich S. Schuler, Uwe Platzbecker, Jens Freiberg‐Richter, A Helwig, (unknown), Christoph Röllig, Ralph Naumann, Frank Kroschinsky, Andreas Neubauer, Gerhard Ehninger	71
20	Correlation between low CSA plasma concentration and severity of acute GvHD in bone marrow transplantation 1988 ·Annals of Hematology ·Helmut Schmidt, Gerhard Ehninger, R. Dopfer, (unknown), Ralph Naumann, Hermann Einsele, (unknown), (unknown), K. Jaschonek, D. Niethammer, H. D. Waller	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact